Cargando…

Structural Analysis and Development of Notum Fragment Screening Hits

[Image: see text] The Wnt signaling suppressor Notum is a promising target for osteoporosis, Alzheimer’s disease, and colorectal cancers. To develop novel Notum inhibitors, we used an X-ray crystallographic fragment screen with the Diamond-SGC Poised Library (DSPL) and identified 59 fragment hits fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuguang, Mahy, William, Willis, Nicky J., Woodward, Hannah L., Steadman, David, Bayle, Elliott D., Atkinson, Benjamin N., Sipthorp, James, Vecchia, Luca, Ruza, Reinis R., Harlos, Karl, Jeganathan, Fiona, Constantinou, Stefan, Costa, Artur, Kjær, Svend, Bictash, Magda, Salinas, Patricia C., Whiting, Paul, Vincent, Jean-Paul, Fish, Paul V., Jones, E. Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264368/
https://www.ncbi.nlm.nih.gov/pubmed/35731924
http://dx.doi.org/10.1021/acschemneuro.2c00325
_version_ 1784742962529304576
author Zhao, Yuguang
Mahy, William
Willis, Nicky J.
Woodward, Hannah L.
Steadman, David
Bayle, Elliott D.
Atkinson, Benjamin N.
Sipthorp, James
Vecchia, Luca
Ruza, Reinis R.
Harlos, Karl
Jeganathan, Fiona
Constantinou, Stefan
Costa, Artur
Kjær, Svend
Bictash, Magda
Salinas, Patricia C.
Whiting, Paul
Vincent, Jean-Paul
Fish, Paul V.
Jones, E. Yvonne
author_facet Zhao, Yuguang
Mahy, William
Willis, Nicky J.
Woodward, Hannah L.
Steadman, David
Bayle, Elliott D.
Atkinson, Benjamin N.
Sipthorp, James
Vecchia, Luca
Ruza, Reinis R.
Harlos, Karl
Jeganathan, Fiona
Constantinou, Stefan
Costa, Artur
Kjær, Svend
Bictash, Magda
Salinas, Patricia C.
Whiting, Paul
Vincent, Jean-Paul
Fish, Paul V.
Jones, E. Yvonne
author_sort Zhao, Yuguang
collection PubMed
description [Image: see text] The Wnt signaling suppressor Notum is a promising target for osteoporosis, Alzheimer’s disease, and colorectal cancers. To develop novel Notum inhibitors, we used an X-ray crystallographic fragment screen with the Diamond-SGC Poised Library (DSPL) and identified 59 fragment hits from the analysis of 768 data sets. Fifty-eight of the hits were found bound at the enzyme catalytic pocket with potencies ranging from 0.5 to >1000 μM. Analysis of the fragments’ diverse binding modes, enzymatic inhibitory activities, and chemical properties led to the selection of six hits for optimization, and five of these resulted in improved Notum inhibitory potencies. One hit, 1-phenyl-1,2,3-triazole 7, and its related cluster members, have shown promising lead-like properties. These became the focus of our fragment development activities, resulting in compound 7d with IC(50) 0.0067 μM. The large number of Notum fragment structures and their initial optimization provided an important basis for further Notum inhibitor development.
format Online
Article
Text
id pubmed-9264368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92643682022-07-09 Structural Analysis and Development of Notum Fragment Screening Hits Zhao, Yuguang Mahy, William Willis, Nicky J. Woodward, Hannah L. Steadman, David Bayle, Elliott D. Atkinson, Benjamin N. Sipthorp, James Vecchia, Luca Ruza, Reinis R. Harlos, Karl Jeganathan, Fiona Constantinou, Stefan Costa, Artur Kjær, Svend Bictash, Magda Salinas, Patricia C. Whiting, Paul Vincent, Jean-Paul Fish, Paul V. Jones, E. Yvonne ACS Chem Neurosci [Image: see text] The Wnt signaling suppressor Notum is a promising target for osteoporosis, Alzheimer’s disease, and colorectal cancers. To develop novel Notum inhibitors, we used an X-ray crystallographic fragment screen with the Diamond-SGC Poised Library (DSPL) and identified 59 fragment hits from the analysis of 768 data sets. Fifty-eight of the hits were found bound at the enzyme catalytic pocket with potencies ranging from 0.5 to >1000 μM. Analysis of the fragments’ diverse binding modes, enzymatic inhibitory activities, and chemical properties led to the selection of six hits for optimization, and five of these resulted in improved Notum inhibitory potencies. One hit, 1-phenyl-1,2,3-triazole 7, and its related cluster members, have shown promising lead-like properties. These became the focus of our fragment development activities, resulting in compound 7d with IC(50) 0.0067 μM. The large number of Notum fragment structures and their initial optimization provided an important basis for further Notum inhibitor development. American Chemical Society 2022-06-22 /pmc/articles/PMC9264368/ /pubmed/35731924 http://dx.doi.org/10.1021/acschemneuro.2c00325 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Zhao, Yuguang
Mahy, William
Willis, Nicky J.
Woodward, Hannah L.
Steadman, David
Bayle, Elliott D.
Atkinson, Benjamin N.
Sipthorp, James
Vecchia, Luca
Ruza, Reinis R.
Harlos, Karl
Jeganathan, Fiona
Constantinou, Stefan
Costa, Artur
Kjær, Svend
Bictash, Magda
Salinas, Patricia C.
Whiting, Paul
Vincent, Jean-Paul
Fish, Paul V.
Jones, E. Yvonne
Structural Analysis and Development of Notum Fragment Screening Hits
title Structural Analysis and Development of Notum Fragment Screening Hits
title_full Structural Analysis and Development of Notum Fragment Screening Hits
title_fullStr Structural Analysis and Development of Notum Fragment Screening Hits
title_full_unstemmed Structural Analysis and Development of Notum Fragment Screening Hits
title_short Structural Analysis and Development of Notum Fragment Screening Hits
title_sort structural analysis and development of notum fragment screening hits
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264368/
https://www.ncbi.nlm.nih.gov/pubmed/35731924
http://dx.doi.org/10.1021/acschemneuro.2c00325
work_keys_str_mv AT zhaoyuguang structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT mahywilliam structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT willisnickyj structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT woodwardhannahl structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT steadmandavid structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT bayleelliottd structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT atkinsonbenjaminn structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT sipthorpjames structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT vecchialuca structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT ruzareinisr structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT harloskarl structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT jeganathanfiona structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT constantinoustefan structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT costaartur structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT kjærsvend structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT bictashmagda structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT salinaspatriciac structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT whitingpaul structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT vincentjeanpaul structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT fishpaulv structuralanalysisanddevelopmentofnotumfragmentscreeninghits
AT joneseyvonne structuralanalysisanddevelopmentofnotumfragmentscreeninghits